Comparison of the effect of TDCS and RTMS in the treatment of migraine

Not Applicable

Recruiting

• Conditions: Migraine.; Migraine

• Registration Number: IRCT20190404043159N4
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

All 18 to 60 years old migraine patients with the code (ICHS-II 1.2.1) according to the International Classification of Headache Disorders (2004) and with a history of migraine attacks (of any severity) during a recent year that is confirmed by a neurologist.
Conscious consent to participate in the study
Have a minimum literacy

Exclusion Criteria

A serious suicide plan or thoughts
Pregnancy or Breastfeeding
Substance abuse
A history of seizures or any neurological disease (other than Migraine)
Having a Pacemaker or any metal Implants in the upper limbs or head and neck
History of any brain stimulation such as ECT(Electroconvulsive therapy)
7. History of taking antidepressants and anti-anxiety drugs from two months before entering the study
Depressive, Bipolar, or Psychotic disorders based on DSM-V (Diagnostic and Statistical Manual of Mental Disorders ) Criteria during examination by a Psychiatrist and Psychiatric Assistant

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity based on Visual Analogue Scale (VAS). Timepoint: At the beginning of the study and one month after the intervention. Method of measurement: Pain intensity based on Visual Analogue Scale (VAS).;Depression score. Timepoint: At the beginning of the study and one month after the intervention. Method of measurement: Based on the Hospital Anxiety and Depression Scale (HADS).;Anxiety score. Timepoint: At the beginning of the study and one month after the intervention. Method of measurement: Based on the Hospital Anxiety and Depression Scale (HADS).;Quality of life score. Timepoint: At the beginning of the study and one month after the intervention. Method of measurement: Based on the Headache Impact Test (HIT) questionnaire.